HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA to hold ICCR prep meeting

This article was originally published in The Rose Sheet

Executive Summary

FDA will hold a public meeting July 7 in Rockville, Md., to prepare for International Cooperation of Cosmetic Regulations meetings being held week of July 12 in Toronto, Canada, according to June 9 Federal Register notice. The Rockville forum will allow agency to furnish information and solicit comment in advance of the ICCR steering committee and expert working group meetings. A coalition formed by regulatory authorities from the U.S., Canada, EU and Japan, ICCR aims to harmonize cosmetics regulations on a global scale and lower barriers to trade while maintaining consumer protections (1"The Rose Sheet" Nov. 3, 2008, In Brief)

You may also be interested in...



International Cooperation on Alternative Test Methods

Alternative method validation organizations from U.S., EU and Japan, together with Health Canada, adopt framework for International Cooperation on Alternative Test Methods, announces European Center for the Validation of Alternative Methods (ECVAM). Initiative is product of September 2007 meeting of the International Cooperation on Cosmetics Regulation, which covered a range of issues including nanotechnology and good manufacturing practices (1"The Rose Sheet" Oct. 15, 2007, p. 4). ICCR also "recognized the importance of replacing, reducing and refining (less pain and distress) animal testing." Framework allows participating organizations to coordinate in designing validation studies, conducting scientific peer reviews and finally developing harmonized recommendations, according to ECVAM, which is joined by U.S. counterpart - the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) - as well as the Japanese Center for the Validation of Alternative Methods and a Canadian government rep. Under adopted schema, one validation organization will act as lead, drafting recommendations based on liaisons with others; if all parties are in agreement, they will finalize and forward recommendation to their respective regulatory authorities

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel